Friday, May 27, 2022
  • Hyderabad
  • Telangana
  • Andhra Pradesh
  • India
  • World
  • Entertainment
  • Science and Tech
  • Sport
  • Business
  • ...
    • NRI
    • View Point
    • cartoon
    • Columns
    • Reviews
    • Education Today
    • Property
    • Videos
    • Lifestyle
E-Paper
  • NRI
  • View Point
  • cartoon
  • Columns
  • Reviews
  • Education Today
  • Property
  • Videos
  • Lifestyle
Home | India | Ocugen To Commercialise Covaxin In Mexico

Ocugen to commercialise Covaxin in Mexico

By Telangana Today
Published: Published Date - 11:42 PM, Mon - 18 April 22
Representational Image

Hyderabad: Biotechnology company Ocugen will commercialise Bharat Biotech’s Covaxin in Mexico. The two companies amended their present co-development, supply and commercialisation agreement on Bharat Biotech’s Covid-19 vaccine Covaxin to include Mexico. With this amendment, Ocugen now has commercialisation rights of Covaxin for all of North America.

“We’re excited to commercialise Covaxin in Mexico, as authorities there have made conquering this pandemic a major priority. After meeting with Mexico’s Secretary of Foreign Affairs, Marcelo Ebrard, in Delhi, we are encouraged by the role Covaxin can play in Mexico’s continuing efforts to defeat the Covid-19 pandemic,’‘ Shankar Musunuri, Chairman of the Board, Chief Executive Officer and Co-founder, Ocugen said in a release.

“Covaxin is currently under review by Comisión Federal para la Protección contra Riesgos Sanitarios (COFEPRIS) for emergency use among children between 2 and 18,” he added.

“We are delighted to announce our partnership with Ocugen for Mexico, along with the United States and Canada. Covaxin is a safe and efficacious inactivated vaccine for all age groups as evident from its data from global introduction,” said Dr Krishna Ella, Chairman and Managing Director, Bharat Biotech.


Now you can get handpicked stories from Telangana Today on Telegram everyday. Click the link to subscribe.

Click to follow Telangana Today Facebook page and Twitter .


  • Follow Us :
  • Tags
  • Bharat Biotech
  • Covaxin
  • Mexico
  • Ocugen

Related News

  • Covaxin receives emergency use approval in children aged between 6 and 12

  • Bharat Biotech asked to provide more data on COVID-19 vaccine Covaxin for below 12-year-olds

  • Covaxin, Covishield to cost Rs 225 per dose

  • Bharat Biotech announces slowing down of Covaxin production

  • Bharat Biotech: A journey of 2 suitcases and 40 feet container

  • Next pandemic on animal side and food security, predicts Krishna Ella

Latest News

  • Woman confined in room, molested and assaulted in Hyderabad

    12 mins ago
  • Hyderabad: RoB at Kaithalapur to be inaugurated next month

    32 mins ago
  • TRS continues tirade against PM, dares to go for early polls

    39 mins ago
  • Vinod Kumar condemns Modi’s comment on KCR family

    19 mins ago
  • Kishan Reddy slams TRS over remarks on Modi

    1 hour ago
  • Hyderabad: Cop’s timely response saves life of man

    1 hour ago
  • Hyderabad: Case against firm in family suicide attempt incident

    1 hour ago
  • SAI forms 3-member panel to look into gymnast Aruna’s allegations

    1 hour ago

company

  • Home
  • About Us
  • Contact Us

business

  • Subscribe

telangana today

  • Telangana
  • Hyderabad
  • Latest News
  • Entertainment
  • World
  • Andhra Pradesh
  • Science & Tech
  • Sport

follow us

© Copyrights 2022 TELANGANA PUBLICATIONS PVT. LTD. All rights reserved. Powered by Veegam